Article

Year in Review: Patients Recount Their Personal Battles with Specialty Diseases

Author(s):

Lauren Santye, Assistant Editor

Patients share their personal stories with Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/year-in-review-patients-recount-their-personal-bat" target="_blank">View the story "Year in Review: Patients Recount Their Personal Battles with Specialty Diseases " on Storify</a>]

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Breast cancer and SERDs -- Image credit: Phongsakorn | stock.adobe.com
August 28th 2025

Oral SERDs in Breast Cancer: Imulnestrant and Elacestrant

Gillian McGovern, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 28th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Small cell lung cancer (SCLC) -- Image credit: Saiful52 | stock.adobe.com
August 28th 2025

FDA Grants I-DXd Breakthrough Therapy Designation in Treatment of ES-SCLC

Gillian McGovern, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 28th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Wegovy injection pens | Image Credit: © Patrick Bay Damsted - stock.adobe.com
August 28th 2025

Study Finds GLP-1 Receptor Agonists May Reduce Cancer Risk in Adults with Obesity

Alexandra Gerlach, Associate Editor
In the hospital, the patient undergoes a screening procedure for a mammogram, which is performed by a mammogram. A modern technologically advanced clinic with professional doctors. Image Credit: Valerii Apetroaiei | stock.adobe.com
August 28th 2025

Suppression of JNK Pathway Drives Resistance to Endocrine and CDK4/6 Therapy in ER-Positive Breast Cancer

Danielle Valletti, Assistant Editor